These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8884307)

  • 1. Hepatitis C and the controversies it creates relative to liver transplantation and autoimmune hepatitis.
    Bayraktar Y; Van Thiel DH; Gurakar A
    Hepatogastroenterology; 1996; 43(10):873-81. PubMed ID: 8884307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus and autoimmune hepatitis: coincidence or causal relationship?].
    Dienes HP; Lohse A; Schirmacher P
    Verh Dtsch Ges Pathol; 1996; 80():178-80. PubMed ID: 9064998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
    Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
    Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
    Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Ann Ital Med Int; 1996; 11(2):119-24. PubMed ID: 8974437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviruses in autoimmune liver disease: genetic or environmental agents?
    Mason AL; Xu L; Guo L; Garry RF
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):289-97. PubMed ID: 10604234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune hepatitis: when should treatment be discontinued?].
    Marín López E; Marín-Sotomayor A; Rosano García A
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S76-81. PubMed ID: 9102787
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
    Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
    Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
    Di Martino V; Saurini F; Samuel D; Gigou M; Dussaix E; Reynès M; Bismuth H; Féray C
    Hepatology; 1997 Nov; 26(5):1343-50. PubMed ID: 9362382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of patient and graft survival following liver transplantation for hepatitis C.
    Charlton M; Seaberg E; Wiesner R; Everhart J; Zetterman R; Lake J; Detre K; Hoofnagle J
    Hepatology; 1998 Sep; 28(3):823-30. PubMed ID: 9731579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.